Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study Comparing the Occurrence of Actinic Keratoses on the Face in High-Risk Individuals After Cryotherapy + Photodynamic Therapy With Levulan Topical Solution + Blue Light Versus Cryotherapy + Vehicle Topical Solution + Blue Light

NCT02239679 is registered in ClinicalTrials.gov with DUSA Pharmaceuticals, Inc. as lead sponsor.

NCT NCT02239679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02239679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study Comparing the Occurrence of Actinic Keratoses on the Face in High-Risk Individuals After Cryotherapy + Photodynamic Therapy With Levulan Topical Solution + Blue Light Versus Cryotherapy + Vehicle Topical Solution + Blue Light
Lead sponsor
DUSA Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
September 30, 2016
Enrollment
166 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis